From the early stages of tumor initiation, immunosuppressive regulatory T lymphocytes and Gr1+CD11b+ myeloid-derived suppressor cells are recruited to the tumor stroma, restraining the T-cell-mediated antitumor immunity [40]. The gene discussed is ITGAM; the disease is neoplasm.